In 2018, Pacific BioLabs decided not to renew its ISO 9001 and ISO 13485 certificates, opting instead to become ISO 17025 certified. Being a testing lab and not a medical device manufacturer, ISO 17025 is more pertinent to PBL than 9001 and 13485. PBL understands that continuous improvement is crucial its success and we are […]
PBL’s Vice President of Analytical Chemistry was interviewed by BioPharm International for an article titled, Analytical Best Practices for Raw Material Testing. Pacific BioLabs performs testing on raw materials for many different clients. Please contact PBL for your raw material testing needs. The BioPharm International article can be found here.
Pacific BioLabs has purchased and validated a QuickPlex SQ 120 MSD instrument and we are now accepting requests for MSD studies. The instrument will be used for immunogenicity testing, biomarker analysis, PK/PD bioanalysis, product development and release assays as well as R&D studies. For a limited time, MSD has offered PBL a discounted rate on […]
Trade Shows and Events
PBL will be attending SOT’s 58th Annual Meeting and ToxExpo in Baltimore. With more than 80 scientific sessions, over 300 exhibitors and 2,100 abstract presentations, SOT’s annual meeting is the largest toxicology conference in the country. If you’re attending, stop by the PBL booth at 3413 to discuss PBL’s toxicology capabilities.
The BIO International Convention attracts over 16,000 biotech and pharmaceutical leaders from over 7,000 companies. Sessions span a wide spectrum including drug discovery, biomanufacturing, genomics, biofuels, nanotechnology and cell therapy. The unique one-on-one partnering system provide a great way to meet new vendors, partners and investors.